Chan Frank has filed 4 insider transactions across 1 company since May 2025.
Most recent transaction: a tax payment of 546 shares of HAEMONETICS CORP ($HAE) on May 15, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | HAEMONETICS CORP | $HAE | Chan Frank | EVP, Chief Operating Officer | F | Common Stock | 546 | $56.29 | 5,401.0000 | 47,668,000 | 9.18% | 0.00% |
| May 15, 2026 | HAEMONETICS CORP | $HAE | Chan Frank | EVP, Chief Operating Officer | A | Common Stock | 27535 | $0.00 | 32,936.0000 | 47,668,000 | 509.81% | 0.06% |
| May 16, 2025 | HAEMONETICS CORP | $HAE | Chan Frank | EVP, Chief Operating Officer | A | Common Stock | 5689 | $0.00 | 5,689.0000 | 50,730,000 | 9999.99% | 0.01% |
| May 16, 2025 | HAEMONETICS CORP | $HAE | Chan Frank | EVP, Chief Operating Officer | A | Non-qualified Stock Option (Right to Buy) | 12317 | $0.00 | 12,317.0000 | 50,730,000 | 9999.99% | 0.02% |